Best practice treatment algorithm for primary open-angle glaucoma: Implications for U.S. ophthalmology practice

Managed Care Interface

Volumn 15, Issue 7, 2002, Pages 37-48

  Serle, Janet ^a   Cantor, Louis ^a   Gross, Ron ^a   Katz, Jay ^a   Mundorf, Thomas ^a   Noecker, Robert ^a   Severin, Todd ^a   Simmons, Steve ^a   Walt, John ^a   Casciano, Julian ^a   Evans, Stacy ^a   Doyle, John ^a  

^a Analytica Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; LATANOPROST; PROSTAGLANDIN DERIVATIVE; TIMOLOL;

ALGORITHM; ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG CHOICE; DRUG INDICATION; HEALTH SURVEY; HUMAN; MEDICAL LITERATURE; MEDICAL PRACTICE; OPEN ANGLE GLAUCOMA; OPHTHALMOLOGY; QUESTIONNAIRE; TREATMENT INDICATION; TREATMENT PLANNING; UNITED STATES;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALGORITHMS; BENCHMARKING; DECISION MAKING; DELPHI TECHNIQUE; DISEASE MANAGEMENT; GLAUCOMA, OPEN-ANGLE; HEALTH CARE SURVEYS; HUMANS; OPHTHALMOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SOFTWARE DESIGN; UNITED STATES;

EID: 0036062108     PISSN: 10965645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Racial variations in the prevalence of primary open-angle glaucoma: The Baltimore Eye Survey
2. Office visits for glaucoma: United States, 1991-1992
3. Results for the United States (chapter 14)
4. Initial treatment for open-angle glaucoma - Medical, laser, or surgical? Medication is the treatment of choice for chronic open-angle glaucoma
5. The use of consensus methods and expert panels in pharmacoeconomic studies - Practical applications and methodological shortcomings
6. Expert opinion regarding indications for coronary angiography before noncardiac surgery
7. Coronary angiography and bypass surgery in Manitoba and the United States: A first comparison
8. Policy priorities in diabetes care: A Delphi study
9. The Delphi method as a consensus and knowledge acquisition tool for the evaluation of the Diabetes system for insulin administration
10. Effect of local standards on the implementation of national guidelines for asthma: Primary care agreement with national asthma guidelines
11. Does this patient need to be evaluated today? Designing a guideline-driven triage process to determine the timing of care for adults with respiratory infection symptoms
12. Evidence-based medicine regarding the prevention of retinal detachment
13. Evidence-based analysis of prophylactic treatment of asymptomatic retinal breaks and lattice degeneration
14. Comparison of the effect of alphagan 0.2% versus trusopt 2.0% in combination with beta-blockers
15. Cost analysis of glaucoma medications
16. Unsuspected bronchospasm in association with topical timolol - A common problem in elderly people: Can we easily identify those affected and do cardioselective agents lead to improvement?
17. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution
18. Beta-blockers and the elderly with glaucoma: Are we adding insult to injury?
19. Antiglaucoma medications: A review of safety and tolerability issues related to their use
20. Beta-blockers-induced complications and the patient with glaucoma
21. The potential systemic effect of topically applied b-blockers in glaucoma therapy
22. A 1 year study of brimonidine twice daily in glaucoma and ocular hypertension: A controlled, randomized, multicenter clinical trial
23. Neuroprotective effect of brimonidine on adult rat retina ganglion cells after increased intraocular pressure
24. Functional protection of rat retina from ischemic injury by brimonidine
25. Brimonidine protects photoreceptors and visual function after light damage
26. Activation of cell survival signaling pathway in the retina by selective alpha-2 adrenoreceptor agonist brimonidine
27. Anti-glaucoma agent brimonidine protects retinal function after ischemic injury
28. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension
29. Medical treatment patterns of ASCRS members for primary open-angle glaucoma-1998 survey